Page last updated: 2024-08-23

fosinopril and fosinoprilat

fosinopril has been researched along with fosinoprilat in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19904 (14.29)18.7374
1990's12 (42.86)18.2507
2000's7 (25.00)29.6817
2010's4 (14.29)24.3611
2020's1 (3.57)2.80

Authors

AuthorsStudies
Auch-Schwelk, W; Bossaller, C; Claus, M; Fleck, E; Graf, K; Gräfe, M1
Duchin, KL; Frantz, M; Manning, J; Tu, JI; Waclawski, AP; Willard, DA1
Cushman, DW; Dzwonczyk, S; Fung, W; Grover, GJ; Sleph, PG; Tobias, D; Wang, P1
Abboa-Offei, B; Seymour, AA; Swerdel, JN1
Andersen, AR; Ibsen, H; Paulson, OB; Rasmussen, S; Strandgaard, S; Waldemar, G1
Brennan, J; Eckelman, WC; Stouffer, B; Tu, JI1
Cushman, DW; DeForrest, JM; Harvey, C; Petrillo, EW; Powell, JR; Rubin, B; Scalese, B; Waldron, TL1
Mackaness, GB1
Cohen, AI; Ivashkiv, E; Jemal, M; Ribick, M1
Alpaugh, WC; Stauber, KL; Swanson, BN; Weinstein, SH1
Baker, JR; Bigby, TD; Kylstra, TA1
Ford, NF; Hammett, JL; Lasseter, KC; Manning, J; Raymond, R; Van Harken, DR1
Duchin, KL; Gehr, TW; Grasela, DM; Sica, DA1
Casaretto, H; Hauswirth, O; Koppers, D; Lemke, P; Räcke, HF1
Delaney, C; Garland, WT; Kostis, JB; Liao, WC; Norton, J1
Chu, KM; Ding, PY; Hu, OY; Huang, CS; Hwang, GM1
Caspi, A; Greenbaum, R; Liao, WC; Mangold, B; Nouriel, H; O'Grady, P; Paz, R; Sclarovsky, S; Yee, KF; Zucchelli, P1
Jemal, M; Mulvana, DE1
Huang, M; Jemal, M; Mao, Y; Schuster, A; Whigan, D1
Burnett , JC; Chen, HH; Harty, GJ; Lainchbury, JG; Matsuda, Y1
Bartels, T; Betge, S; Dendorfer, A; Dominiak, P; Raasch, W1
Dimkovic, N; Ivanovic, D; Jancic, B; Malenovic, A; Medenica, M1
Ivanović, D; Janci, B; Malenović, A; Marković, S; Medenica, M1
Hu, L; Hu, Y; Huang, J; Li, G; Si, L; Sun, X; Xue, K1
Abu Hasan, Z'; Acharya, KR; Cozier, GE; Isaac, RE; Ismail, NM; Othman, H; Williams, H1
Acharya, KR; Cashman, JS; Cozier, GE; Harrison, C; Isaac, RE1
Abbulu, K; Bhende, SD; Varanasi, MB1
Berlicki, Ł; Kafarski, P; Mucha, A1

Trials

4 trial(s) available for fosinopril and fosinoprilat

ArticleYear
Pharmacokinetics, safety, and pharmacologic effects of fosinopril sodium, an angiotensin-converting enzyme inhibitor in healthy subjects.
    Journal of clinical pharmacology, 1991, Volume: 31, Issue:1

    Topics: Adolescent; Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Drug Evaluation; Fosinopril; Humans; Male; Organophosphorus Compounds; Peptidyl-Dipeptidase A; Proline; Single-Blind Method

1991
The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients.
    European journal of clinical pharmacology, 1993, Volume: 45, Issue:5

    Topics: Administration, Oral; Adult; Biological Availability; Biotransformation; Feces; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Renal Dialysis

1993
Fosinopril: pharmacokinetics and pharmacodynamics in congestive heart failure.
    Clinical pharmacology and therapeutics, 1995, Volume: 58, Issue:6

    Topics: Administration, Oral; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Biological Availability; Cross-Over Studies; Female; Fosinopril; Heart Failure; Humans; Injections, Intravenous; Male; Matched-Pair Analysis; Middle Aged; Prodrugs

1995
Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency.
    British journal of clinical pharmacology, 2000, Volume: 49, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalaprilat; Female; Fosinopril; Heart Failure; Humans; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Peptidyl-Dipeptidase A; Time Factors

2000

Other Studies

24 other study(ies) available for fosinopril and fosinoprilat

ArticleYear
Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
    Journal of cardiovascular pharmacology, 1992, Volume: 20 Suppl 9

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Captopril; Cattle; Coronary Vessels; Dipeptides; Enalaprilat; Endothelium, Vascular; Fosinopril; Humans; In Vitro Techniques; Lisinopril; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroarginine; Ramipril; Receptors, Bradykinin; Receptors, Neurotransmitter; Vasodilation; Vasodilator Agents

1992
Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 257, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Disease; Drug Stability; Enalaprilat; Fosinopril; Heart; In Vitro Techniques; Male; Myocardium; Organophosphorus Compounds; Prodrugs; Proline; Pyrroles; Ramipril; Rats; Rats, Inbred Strains; Sulfhydryl Compounds

1991
Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme.
    Journal of cardiovascular pharmacology, 1991, Volume: 17, Issue:3

    Topics: Amino Acids; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Fosinopril; Hypertension; Male; Neprilysin; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Sulfhydryl Compounds

1991
The effect of fosinopril sodium on cerebral blood flow in moderate essential hypertension.
    American journal of hypertension, 1990, Volume: 3, Issue:6 Pt 1

    Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Cerebrovascular Circulation; Chlorthalidone; Female; Fosinopril; Humans; Hypertension; Lower Body Negative Pressure; Male; Middle Aged; Organophosphorus Compounds; Proline; Rest; Tomography, Emission-Computed, Single-Photon

1990
A radioimmunoassay for SQ 27,519, the active phosphinic acid-carboxylic diacid of the prodrug fosinopril in human serum.
    Therapeutic drug monitoring, 1990, Volume: 12, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Availability; Blood Proteins; Carbon Radioisotopes; Chromatography, Thin Layer; Cross Reactions; Fosinopril; Humans; Injections, Intravenous; Organophosphorus Compounds; Prodrugs; Proline; Protein Binding; Rabbits; Radioimmunoassay

1990
Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
    Journal of cardiovascular pharmacology, 1989, Volume: 14, Issue:5

    Topics: Acute Kidney Injury; Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Dogs; Fosinopril; Heart Rate; Injections, Intravenous; Macaca fascicularis; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred Strains; Sympathetic Nervous System; Time Factors

1989
The future of angiotensin-converting enzyme inhibitors.
    Journal of cardiovascular pharmacology, 1985, Volume: 7 Suppl 1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Binding Sites; Captopril; Diuretics; Fosinopril; Humans; Intestinal Absorption; Kinetics; Organophosphorus Compounds; Renin; Snake Venoms; Zinc

1985
Determination of SQ 27,519, the active phosphinic acid-carboxylic acid of the prodrug SQ 28,555, in human serum by capillary gas chromatography with nitrogen-phosphorus detection after a two-step derivatization.
    Journal of chromatography, 1985, Dec-13, Volume: 345, Issue:2

    Topics: Chemical Phenomena; Chemistry; Chromatography, Gas; Fosinopril; Humans; Hydrolysis; Indicators and Reagents; Mass Spectrometry; Proline

1985
Radioenzymatic assay of angiotensin-converting enzyme inhibitors in plasma and urine.
    Analytical biochemistry, 1985, Aug-01, Volume: 148, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biological Availability; Dogs; Enalapril; Enalaprilat; Fosinopril; Haplorhini; Hydrolysis; Male; Proline; Rats

1985
Effects of metalloproteinase inhibitors on leukotriene A4 hydrolase in human airway epithelial cells.
    Biochemical pharmacology, 1995, Sep-28, Volume: 50, Issue:7

    Topics: Aminopeptidases; Captopril; Cell Line; Cell-Free System; Epithelium; Epoxide Hydrolases; Fosinopril; Humans; Kinetics; Leucine; Leukotriene B4; Metalloendopeptidases; Neutrophils; Protease Inhibitors

1995
Single-dose and steady-state pharmacokinetics of fosinopril and fosinoprilat in patients with hepatic impairment.
    Journal of clinical pharmacology, 1995, Volume: 35, Issue:2

    Topics: Antihypertensive Agents; Creatinine; Female; Fosinopril; Humans; Liver Cirrhosis, Alcoholic; Male; Metabolic Clearance Rate; Middle Aged; Prodrugs

1995
Fosinoprilate prolongs the action potential: reduction of iK and enhancement of the L-type calcium current in guinea pig ventricular myocytes.
    Cardiovascular research, 1994, Volume: 28, Issue:2

    Topics: Action Potentials; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Calcium-Transporting ATPases; Cells, Cultured; Computer Simulation; Fosinopril; Guinea Pigs; Heart Ventricles; Ion Pumps; Male; Models, Cardiovascular; Sodium-Potassium-Exchanging ATPase

1994
Pharmacokinetics of fosinoprilat in Chinese and whites after intravenous administration.
    Journal of clinical pharmacology, 1997, Volume: 37, Issue:9

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Asian People; China; Fosinopril; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; White People

1997
Liquid chromatographic-electrospray tandem mass spectrometric method for the simultaneous quantitation of the prodrug fosinopril and the active drug fosinoprilat in human serum.
    Journal of chromatography. B, Biomedical sciences and applications, 2000, Mar-10, Volume: 739, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Chromatography, Liquid; Fosinopril; Humans; Mass Spectrometry; Prodrugs; Reference Standards; Reproducibility of Results; Sensitivity and Specificity

2000
Liquid chromatography/electrospray tandem mass spectrometry method for the quantitation of fosinoprilat in human serum using automated 96-well solid-phase extraction for sample preparation.
    Rapid communications in mass spectrometry : RCM, 2000, Volume: 14, Issue:12

    Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chromatography, Liquid; Fosinopril; Humans; Hydrolysis; Mass Spectrometry; Quality Control; Reference Standards; Reproducibility of Results; Sensitivity and Specificity

2000
Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.
    Hypertension (Dallas, Tex. : 1979), 2001, Volume: 38, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Dogs; Fosinopril; Glomerular Filtration Rate; Heart Failure; Male; Neprilysin; Polysaccharides; Protease Inhibitors; Pyridines; Receptors, Atrial Natriuretic Factor; Sodium; Thiazepines

2001
Angiotensin converting enzyme inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive rats.
    Journal of hypertension, 2001, Volume: 19, Issue:10

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Dose-Response Relationship, Drug; Fosinopril; Heart Conduction System; Heart Ventricles; In Vitro Techniques; Male; Myocardium; Neurons; Norepinephrine; Rats; Rats, Inbred SHR; Time Factors

2001
Development of liquid chromatographic method for fosinoprilat determination in human plasma using microemulsion as eluent.
    Journal of chromatography. A, 2005, Sep-23, Volume: 1088, Issue:1-2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Calibration; Chromatography, High Pressure Liquid; Emulsions; Fosinopril; Humans; Renal Dialysis; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet

2005
Microemulsion liquid chromatographic method for characterisation of fosinopril sodium and fosinoprilat separation with chemometrical support.
    Analytical and bioanalytical chemistry, 2005, Volume: 383, Issue:4

    Topics: Chromatography, High Pressure Liquid; Emulsions; Fosinopril; Reproducibility of Results; Sensitivity and Specificity

2005
Simultaneous quantification of fosinopril and its active metabolite fosinoprilat in rat plasma by UFLC-MS/MS: Application of formic acid in the stabilization of an ester-containing drug.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2015, May-15, Volume: 990

    Topics: Animals; Chromatography, High Pressure Liquid; Drug Stability; Formates; Fosinopril; Linear Models; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry

2015
The toxicity of angiotensin converting enzyme inhibitors to larvae of the disease vectors Aedes aegypti and Anopheles gambiae.
    Scientific reports, 2017, 03-27, Volume: 7

    Topics: Aedes; Angiotensin-Converting Enzyme Inhibitors; Animals; Anopheles; Captopril; Disease Vectors; Fosinopril; Humans; Insecticide Resistance; Insecticides; Larva; Mosquito Vectors; Peptidyl-Dipeptidase A

2017
Crystal structures of angiotensin-converting enzyme from Anopheles gambiae in its native form and with a bound inhibitor.
    The Biochemical journal, 2019, 11-29, Volume: 476, Issue:22

    Topics: Aedes; Angiotensin-Converting Enzyme Inhibitors; Animals; Anopheles; Drosophila melanogaster; Fosinopril; Humans; Insect Proteins; Insecticides; Larva; Models, Molecular; Peptidyl-Dipeptidase A

2019
A sensitive and efficient LC-MS/MS method for the bioanalysis of fosinopril diacid from human plasma and its application for a bioequivalence study in humans.
    Biomedical chromatography : BMC, 2021, Volume: 35, Issue:5

    Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Chromatography, High Pressure Liquid; Fosinopril; Humans; Male; Reference Standards; Tandem Mass Spectrometry; Therapeutic Equivalency

2021
Remarkable potential of the α-aminophosphonate/phosphinate structural motif in medicinal chemistry.
    Journal of medicinal chemistry, 2011, Sep-08, Volume: 54, Issue:17

    Topics: Amino Acid Motifs; Chemistry, Pharmaceutical; Humans; Organophosphonates; Phosphinic Acids

2011